Scientific Reports (Apr 2022)
Author Correction: Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534
- Xiaohua Xue,
- Aimee De Leon-Tabaldo,
- Rosa Luna-Roman,
- Glenda Castro,
- Michael Albers,
- Freddy Schoetens,
- Samuel DePrimo,
- Damayanthi Devineni,
- Thomas Wilde,
- Steve Goldberg,
- Olaf Kinzel,
- Thomas Hoffmann,
- Anne M. Fourie,
- Robin L. Thurmond
Affiliations
- Xiaohua Xue
- Janssen Research & Development, LLC
- Aimee De Leon-Tabaldo
- Janssen Research & Development, LLC
- Rosa Luna-Roman
- Janssen Research & Development, LLC
- Glenda Castro
- Janssen Research & Development, LLC
- Michael Albers
- Department of Research, Phenex Pharmaceuticals AG
- Freddy Schoetens
- Janssen Research & Development, LLC
- Samuel DePrimo
- Janssen Research & Development, LLC
- Damayanthi Devineni
- Janssen Research & Development, LLC
- Thomas Wilde
- Janssen Research & Development, LLC
- Steve Goldberg
- Janssen Research & Development, LLC
- Olaf Kinzel
- Department of Research, Phenex Pharmaceuticals AG
- Thomas Hoffmann
- Department of Research, Phenex Pharmaceuticals AG
- Anne M. Fourie
- Janssen Research & Development, LLC
- Robin L. Thurmond
- Janssen Research & Development, LLC
- DOI
- https://doi.org/10.1038/s41598-022-09558-2
- Journal volume & issue
-
Vol. 12,
no. 1
pp. 1 – 2
Abstract
No abstracts available.
